Polymorphisms in the CXCR2 gene can alter the pharmacodynamics of drugs like cyclophosphamide, impacting their efficacy and safety by modifying the receptor's expression or function. This effect is significant in treating conditions such as cancer and inflammatory diseases, where CXCR2 plays a crucial role, making the understanding of these genetic variations essential for personalized medication strategies and optimizing treatment outcomes.